QORIA LIMITED (QOR)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

QOR - QORIA LIMITED

FNArena Sector : Software & Services
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: -2.12
Index: ALL-ORDS | ALL-TECH

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.47

04 Feb
2025

-0.005

OPEN

$0.47

-1.05%

HIGH

$0.48

1,080,713

LOW

$0.47

TARGET
$0.54 14.9% upside
OTHER COMPANIES IN THE SAME SECTOR
360 . AHI . ALC . AMX . ATA . BMT . COS . DOC . EVS . GTK . KYP . NET . NXL . RDY . SKO . UBN . VGL . XF1 . YOJ . Z2U .
FNARENA'S MARKET CONSENSUS FORECASTS
QOR: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx - 4.9 - 2.1 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-4.9
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx99.4 M
Book Value Per Share xxxxxxxxxxxxxxx11.6
Net Operating Cash Flow xxxxxxxxxxxxxxx6.8 M
Net Profit Margin xxxxxxxxxxxxxxx-55.07 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-36.91 %
Return on Invested Capital xxxxxxxxxxxxxxx-32.41 %
Return on Assets xxxxxxxxxxxxxxx-18.73 %
Return on Equity xxxxxxxxxxxxxxx-36.91 %
Return on Total Capital xxxxxxxxxxxxxxx-28.88 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx0.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx8 M
Long Term Debt xxxxxxxxxxxxxxx36 M
Total Debt xxxxxxxxxxxxxxx44 M
Goodwill - Gross xxxxxxxxxxxxxxx170 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx9 M
Price To Book Value xxxxxxxxxxxxxxx3.70

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx6.0 M
Capex % of Sales xxxxxxxxxxxxxxx6.00 %
Cost of Goods Sold xxxxxxxxxxxxxxx139 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx12 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

xx/xx/xxxx

1

xxx, xxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

22/01/2025

1

Buy

$0.56

19.15%

Qoria delivered a strong 2Q FY25 performance, in Ord Minnett's view, with annual recurring revenue (ARR) rising by $12m quarter-on-quarter to $132m, including a $7m foreign exchange tailwind.

Segment performance across the US, UK, and A&NZ was robust, notes the broker, with growth of 27%, 12%, and 51% year-on-year, respectively.

The closing weighted pipeline of $11m was up 70% year-on-year, indicating to the analysts strong growth potential for H2.

Ord Minnett raises its price target to $0.56 from $0.51 and retains a Buy rating, citing Qoria’s attractive valuation and positioning for further growth.

FORECAST
Ord Minnett forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -2.30 cents.
Ord Minnett forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -0.30 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Wilsons

22/01/2025

1

Overweight

$0.57

21.28%

Wilsons highlights Qoria produced strong annual recurring revenue (ARR) growth in 2Q25, mainly from a $7m forex benefit. Excluding that, the company still added net ARR of $5m in the quarter vs Wilsons' expectation of $4.6m.

The broker sees Qoria well placed heading into the 2H driven by its record sales pipeline of around $32m vs $17m in the previous corresponding period.

The price target increases to 57c from 55c driven mainly by a 4% FY25 revenue forecast increase. Overweight rating stays.

FORECAST
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -1.80 cents.
Wilsons forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -0.50 cents.
Access Extra Coverage Research History >

QOR STOCK CHART

FNArena News on QOR

1
Rudi’s View: Cochlear, Guzman y Gomez, SiteMinder, Wesfarmers & Xero

Jan 30 2025 - Rudi's View
2
Rudi’s View: Feb Season’s Best Buys & Key Picks

Jan 23 2025 - Rudi's View
3
Australian Broker Call *Extra* Edition – Jan 23, 2025

Jan 23 2025 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Jan 22, 2025

Jan 22 2025 - Daily Market Reports
5
Rudi’s View: Best Buys & Convictions For 2025

Jan 16 2025 - Rudi's View

Latest Software & Services News

1
DeepSeek & More AI Excitement For 2025

Jan 28 2025 - Feature Stories
2
Xero: The Pause That Refreshes

Jan 23 2025 - Technicals
3
Pro Medicus, A Global Software Super Star

Dec 19 2024 - Australia
4
Higher Margins Underpin Gentrack’s Ambitions

Nov 28 2024 - Small Caps
5
Targets Jump For Embattled WiseTech

Nov 28 2024 - Australia
6
Nuix Rises From The Ashes

Nov 08 2024 - Small Caps
7
WiseTech In Global Supply Chain Sweet Spot

Oct 10 2024 - Australia
8
Quality By Any Objective Measure

Oct 04 2024 - Small Caps
9
Gen.Ai: Infrastructure Arms Race Powers Ahead

Sep 16 2024 - International
10
Gentrack Shares Breaking Out

Sep 10 2024 - Technicals